TORONTO, Dec. 18, 2012 /CNW/ - Patheon Inc. (TSX: PTI) ("Patheon" or the "Company") today reminded holders of its
restricted voting shares that the Company's current rights offering
will expire in 10 days, on December 28, 2012. Rights certificates were
mailed on December 3, 2012 to each registered holder of restricted
voting shares resident in Canada and the U.S. as of November 27, 2012.
Under the terms of the rights offering, all registered holders of rights
must validly deliver their completed rights certificates to the
subscription agent, Computershare Investor Services Inc., before the
expiry deadline on December 28, 2012, at 5:00 p.m. (Toronto time),
accompanied by payment of the total applicable subscription price, in
order to exercise their subscription rights. The rights will cease
trading on the Toronto Stock Exchange at noon (Toronto time) on
December 28, 2012.
An earlier deadline will apply for rights held through securities
brokers, dealers, banks, trust companies or other custodians that
participate directly or indirectly in the book-entry systems
administered by CDS Clearing and Depository Services Inc. or the
Depository Trust Company. Holders of such rights should contact their
broker, dealer, bank, trust company or other custodian to determine the
deadlines applicable to them.
The Company has filed a registration statement (including a prospectus)
with the U.S. Securities and Exchange Commission (the "SEC") for the
offering to which this communication relates. Before U.S. residents
invest, they should read the prospectus in that registration statement
and other documents the Company has filed with the SEC for more
complete information about the Company and the offering. These
documents are available for free by visiting EDGAR on the SEC web site
at www.sec.gov. This offering is also being made by means of an offering circular in
Canada. The Canadian offering circular is available on SEDAR. Copies of
the offering circular or prospectus may also be obtained by contacting
the Company by telephone at (919) 226-3200 or by email at email@example.com, or Computershare Investor Services Inc., the subscription agent, by
telephone at 1-800-564-6253 or by email at firstname.lastname@example.org.
About Patheon Inc.
Patheon Inc. (TSX: PTI) is a leading global provider of contract
development and manufacturing services to the global pharmaceutical
industry. The Company provides the highest quality products and
services to approximately 300 of the world's leading pharmaceutical and
biotechnology companies. Patheon's services range from preclinical
development through commercial manufacturing of a full array of solid
and sterile dosage forms.
The Company's comprehensive range of fully integrated Pharmaceutical
Development Services includes pre-formulation, formulation, analytical
development, clinical manufacturing, scale-up and commercialization.
The Company's integrated development and manufacturing network of nine
manufacturing facilities and nine development centers across North
America and Europe, enables customer products to be launched with
confidence anywhere in the world. For more information visit www.Patheon.com.
Caution Concerning Forward-Looking Statements
This press release contains forward-looking statements which reflect the
Company's expectations regarding its proposed rights offering. All
statements, other than statements of historical fact, are
forward-looking statements. Wherever possible, words such as "plans",
"expects" or "does not expect", "forecasts", "anticipates" or "does not
anticipate", "believes", "intends" and similar expressions or
statements that certain actions, events or results "may", "could",
"should", "would", "might" or "will" be taken, occur or be achieved
have been used to identify these forward-looking statements.
Forward-looking statements necessarily involve significant known and
unknown risks, assumptions and uncertainties that may cause the
Company's actual results, performance, prospects and opportunities to
differ materially from those expressed or implied by such
forward-looking statements. The Company's current material assumptions
include assumptions related to the level of participation by rights
holders in the rights offering. For additional information regarding
risks and uncertainties that could affect the Company's business,
please see Item 1A "Risk Factors" in our Annual Report on Form 10-K for
the fiscal year ended October 31, 2012 and the Company's subsequent
filings with the SEC and the Canadian Securities Administrators.
Although the Company has attempted to identify important risks and
factors that could cause actual actions, events or results to differ
materially from those described in forward-looking statements, there
may be other factors and risks that cause actions, events or results
not to be as anticipated, estimated or intended. Forward-looking
statements are provided to help stakeholders understand the Company's
expectations and plans as of the date of this release and may not be
suitable for other purposes. There can be no assurance that
forward-looking statements will prove to be accurate, as actual results
and future events could differ materially from those anticipated in
such statements. Accordingly, readers should not place undue reliance
on forward-looking statements. These forward-looking statements are
made as of the date of this press release and, except as required by
law, the Company assumes no obligation to update or revise them to
reflect new events or circumstances.
SOURCE: Patheon Inc.
For further information:
Senior Communications Specialist
919 226 3200
email@example.com (Investor inquiries)